They usually have predetermined readout dates since p values can fluctuate throught data collection and prospectively defining those dates prevents you from being able to just pick the best time for a readout and skew results
Somewhat counterintuitively to frequentists, this is not a problem if they did Bayesian analysis. Many new trails for COVID19 therapeutics are actually reporting realtime Bayesian estimates of efficacy.